Ralph Schiess
Vorstandsvorsitzender bei ONCONETIX, INC.
Vermögen: 32 370 $ am 30.04.2024
Aktive Positionen von Ralph Schiess
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCONETIX, INC. | Vorstandsvorsitzender | 12.01.2024 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 15.12.2023 | - | |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Vorstandsvorsitzender | 01.01.2010 | - |
| Gründer | 01.01.2010 | - | |
| Direktor/Vorstandsmitglied | 01.01.2010 | 01.01.2020 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | 01.05.2023 |
Karriereverlauf von Ralph Schiess
Ausbildung von Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistik
International
| Schweiz | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Börse
- Insiders
- Ralph Schiess
- Erfahrung
